CinRx Pharma, LLC 3
3 · CinCor Pharma, Inc. · Filed Jan 10, 2022
Insider Transaction Report
Form 3
CinRx Pharma, LLC
10% Owner
Holdings
Series A Preferred Stock
→ Common Stock (630,251 underlying)Series B Preferred Stock
→ Common Stock (592,279 underlying)- 2,407,573
Common Stock
Footnotes (1)
- [F1]Each share of Series A Preferred Stock and Series B Preferred Stock will automatically convert into shares of Common Stock on a 3.4:1 basis immediately prior to the closing of the Issuer's initial public offering and have no expiration date.